Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengsheng Li

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
NPJ Vaccines|December 22, 2017
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccinationFengsheng Li, Daniel C Freed, Aimin Tang, et al.
Plos Pathogens|August 4, 2020
Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment stepXiaohua Ye, Hang Su, Daniel Wrapp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2009
PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccinationAdam C Finnefrock, Aimin Tang, Fengsheng Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccineDaniel C Freed, Qi Tang, Aimin Tang, et al.
The Journal of Biological Chemistry|May 8, 2015
Soluble Human Cytomegalovirus gH/gL/pUL128-131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing EpitopesJohn W Loughney, Richard R Rustandi, Dai Wang, et al.
Science Advances|March 11, 2022
Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodiesDaniel Wrapp, Xiaohua Ye, Zhiqiang Ku, et al.
Science Translational Medicine|November 1, 2016
A replication-defective human cytomegalovirus vaccine for prevention of congenital infectionDai Wang, Daniel C Freed, Xi He, et al.
Journal of Virology|January 13, 2017
Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric ComplexSha Ha, Fengsheng Li, Matthew C Troutman, et al.
Journal of Virology|September 13, 2019
A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural InfectionYaping Liu, Daniel C Freed, Leike Li, et al.
Ebiomedicine|August 1, 2022
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimeraAmy S Espeseth, Maoli Yuan, Michael Citron, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
NPJ Vaccines|December 22, 2017
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccinationFengsheng Li, Daniel C Freed, Aimin Tang, et al.
Plos Pathogens|August 4, 2020
Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment stepXiaohua Ye, Hang Su, Daniel Wrapp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2009
PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccinationAdam C Finnefrock, Aimin Tang, Fengsheng Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccineDaniel C Freed, Qi Tang, Aimin Tang, et al.
The Journal of Biological Chemistry|May 8, 2015
Soluble Human Cytomegalovirus gH/gL/pUL128-131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing EpitopesJohn W Loughney, Richard R Rustandi, Dai Wang, et al.
Science Advances|March 11, 2022
Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodiesDaniel Wrapp, Xiaohua Ye, Zhiqiang Ku, et al.
Science Translational Medicine|November 1, 2016
A replication-defective human cytomegalovirus vaccine for prevention of congenital infectionDai Wang, Daniel C Freed, Xi He, et al.
Journal of Virology|January 13, 2017
Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric ComplexSha Ha, Fengsheng Li, Matthew C Troutman, et al.
Journal of Virology|September 13, 2019
A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural InfectionYaping Liu, Daniel C Freed, Leike Li, et al.
Ebiomedicine|August 1, 2022
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimeraAmy S Espeseth, Maoli Yuan, Michael Citron, et al.
Pageof 10